{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:51:48Z","timestamp":1789167108985,"version":"build-2803163510"},"reference-count":93,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,5,10]]},"DOI":"10.18632\/oncotarget.3434","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T06:34:56Z","timestamp":1442298896000},"page":"10908-10923","source":"Crossref","is-referenced-by-count":39,"title":["Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction"],"prefix":"10.18632","volume":"6","author":[{"given":"Zaid","family":"Al-Wahab","sequence":"first","affiliation":[{"name":"Wayne State University, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Mert","sequence":"additional","affiliation":[{"name":"Wayne State University, Detroit, MI"},{"name":"Division of Gynecologic Oncology, Department of Women's Health, Henry Ford Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Tebbe","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Women's Health, Henry Ford Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasdeep","family":"Chhina","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Women's Health, Henry Ford Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriana","family":"Hijaz","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Women's Health, Henry Ford Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Morris","sequence":"additional","affiliation":[{"name":"Wayne State University, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouba","family":"Ali-Fehmi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Karmanos Cancer Institute, Wayne State University, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Giri","sequence":"additional","affiliation":[{"name":"Department of Neurology, Henry Ford Hospital, Detroit, MI"},{"name":"Josephine Cancer Institute, Henry Ford Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan R.","family":"Munkarah","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Women's Health, Henry Ford Hospital, Detroit, MI"},{"name":"Josephine Cancer Institute, Henry Ford Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramandeep","family":"Rattan","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Women's Health, Henry Ford Hospital, Detroit, MI"},{"name":"Josephine Cancer Institute, Henry Ford Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,3,26]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Jemal","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Ledermann","year":"2014","journal-title":"Lancet"},{"key":"4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2010.01.014","article-title":"Surveillance for the detection of recurrent ovarian cancer: survival impact or lead-time bias?","volume":"117","author":"Bristow","year":"2010","journal-title":"Gynecol Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"3394S","DOI":"10.1093\/jn\/134.12.3394S","article-title":"Effects of energy balance on cancer in genetically altered mice","volume":"134","author":"Hursting","year":"2004","journal-title":"J Nutr"},{"key":"6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/carcin\/bgp280","article-title":"Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research","volume":"31","author":"Perkins","year":"2010","journal-title":"Carcinogenesis"},{"key":"7","first-page":"568","article-title":"Endometrial cancer, obesity, and body fat distribution","volume":"51","author":"Shingleton","year":"1991","journal-title":"Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Thun","year":"2003","journal-title":"N Engl J Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1158\/1055-9965.EPI-04-0880","article-title":"Energy balance and breast cancer risk","volume":"14","author":"Zheng","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1200\/JCO.2013.51.7532","article-title":"Prediagnostic body mass index and pancreatic cancer survival","volume":"31","author":"Wolpin","year":"2013","journal-title":"J Clin Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.ejca.2012.02.063","article-title":"Excess body weight and the risk of primary liver cancer: an updated meta-analysis of prospective studies","volume":"48","author":"Luo","year":"2012","journal-title":"Eur J Cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.7326\/0003-4819-122-5-199503010-00002","article-title":"Physical activity, obesity, and risk for colon cancer and adenoma in men","volume":"122","author":"Willett","year":"1995","journal-title":"Ann Intern Med"},{"key":"13","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.18632\/oncotarget.2168","article-title":"Dietary energy balance modulates ovarian cancer progression and metastasis","volume":"5","author":"Rattan","year":"2014","journal-title":"Oncotarget"},{"key":"14","first-page":"132702","article-title":"Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer","volume":"2014","author":"Song","year":"2014","journal-title":"Biomed Res Int"},{"key":"15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4093\/dmj.2014.38.5.321","article-title":"Molecular links between caloric restriction and sir2\/SIRT1 activation","volume":"38","author":"Wang","year":"2014","journal-title":"Diabetes Me"},{"key":"16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.pharmtox.47.120505.105304","article-title":"AMP-activated protein kinase as a drug target","volume":"47","author":"Hardie","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1741-7007-11-36","article-title":"LKB1 and AMPK and the cancer-metabolism link - ten years after","volume":"11","author":"Alessi","year":"2013","journal-title":"BMC Biol"},{"key":"18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1006\/bbrc.2001.5627","article-title":"Cell cycle regulation via p53 phosphorylation by a 5\u2032-AMP activated protein kinase activator, 5-aminoimidazole-4- carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line","volume":"287","author":"Esumi","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","article-title":"AMP-activated protein kinase induces a p53-dependent metabolic checkpoint","volume":"18","author":"Thompson","year":"2005","journal-title":"Mol Cell"},{"key":"20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ncb1537","article-title":"The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis","volume":"9","author":"Mills","year":"2007","journal-title":"Nat Cell Biol"},{"key":"21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nrm2249","article-title":"AMP-activated\/SNF1 protein kinases: conserved guardians of cellular energy","volume":"8","author":"Hardie","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hawley","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.18632\/aging.100591","article-title":"Rapamycin extends life- and health span because it slows aging","volume":"5","author":"Blagosklonny","year":"2013","journal-title":"Aging (Albany NY)"},{"key":"24","doi-asserted-by":"crossref","first-page":"C4","DOI":"10.1152\/ajpcell.00296.2011","article-title":"A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells","volume":"303","author":"Ruderman","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"25","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/onc.2013.120","article-title":"Sorting out functions of sirtuins in cancer","volume":"33","author":"Chen","year":"2014","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ncomms1001","article-title":"Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer","volume":"1","author":"Serrano","year":"2010","journal-title":"Nat Commun"},{"key":"27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1126\/science.1099196","article-title":"Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase","volume":"305","author":"Sinclair","year":"2004","journal-title":"Science"},{"key":"28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nature08197","article-title":"Recent progress in the biology and physiology of sirtuins","volume":"460","author":"Mostoslavsky","year":"2009","journal-title":"Nature"},{"key":"29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tips.2010.02.003","article-title":"Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases","volume":"31","author":"Guarente","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"30","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Pollak","year":"2006","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00018-007-7080-4","article-title":"Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis","volume":"64","author":"Trajkovic","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Sowers","year":"2002","journal-title":"Ann Intern Med"},{"key":"33","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","article-title":"Investigating metformin for cancer prevention and treatment: the end of the beginning","volume":"2","author":"Pollak","year":"2012","journal-title":"Cancer Discov"},{"key":"34","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Gandini","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"35","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Morris","year":"2005","journal-title":"BMJ"},{"key":"36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ygyno.2014.10.011","article-title":"Old drug, new trick: repurposing metformin for gynecologic cancers?","volume":"135","author":"Romero","year":"2014","journal-title":"Gynecol Oncol"},{"key":"37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cyto.2012.01.015","article-title":"Inflammation and ovarian cancer","volume":"58","author":"Madeddu","year":"2012","journal-title":"Cytokine"},{"key":"38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molmed.2011.01.015","article-title":"VEGF and angiopoietin signaling in tumor angiogenesis and metastasis","volume":"17","author":"Alitalo","year":"2011","journal-title":"Trends Mol Med"},{"key":"39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biochi.2004.10.017","article-title":"AMP-activated protein kinase: balancing the scales","volume":"87","author":"Carling","year":"2005","journal-title":"Biochimie"},{"key":"40","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1074\/jbc.M113.520734","article-title":"Cross-talk between sirtuin and mammalian target of rapamycin complex 1 (mTORC1) signaling in the regulation of S6 kinase 1 (S6K1) phosphorylation","volume":"289","author":"Inoki","year":"2014","journal-title":"J Biol Chem"},{"key":"41","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"AMPK and SIRT1: a long-standing partnership?","volume":"298","author":"Ido","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"42","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/IGC.0b013e31822eb5f8","article-title":"Effect of obesity on survival of women with epithelial ovarian cancer: a systematic review and meta-analysis of observational studies","volume":"21","author":"Park","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"43","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2011.06.038","article-title":"Use of metformin and the risk of ovarian cancer: a case-control analysis","volume":"123","author":"Meier","year":"2011","journal-title":"Gynecol Oncol"},{"key":"44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/AOG.0b013e3182393ab3","article-title":"Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity","volume":"119","author":"Lengyel","year":"2012","journal-title":"Obstet Gynecol"},{"key":"45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cncr.27706","article-title":"Metformin intake is associated with better survival in ovarian cancer: a case-control study","volume":"119","author":"Shridhar","year":"2013","journal-title":"Cancer"},{"key":"46","first-page":"57","article-title":"Metformin in cancer prevention and therapy","volume":"2","author":"Drzewoski","year":"2014","journal-title":"Ann Transl Med"},{"key":"47","first-page":"65","article-title":"Mechanisms linking excess adiposity and carcinogenesis promotion","volume":"5","author":"Fruhbeck","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms","volume":"4","author":"Kaaks","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1017\/S0029665108006976","article-title":"Obesity and cancer","volume":"67","author":"Boeing","year":"2008","journal-title":"Proc Nutr Soc"},{"key":"50","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1200\/JCO.2010.27.9935","article-title":"Energy balance, host-related factors, and cancer progression","volume":"28","author":"Berger","year":"2010","journal-title":"J Clin Oncol"},{"key":"51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.tem.2006.08.006","article-title":"Obesity and cancer risk: the role of the insulin-IGF axis","volume":"17","author":"Flyvbjerg","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"52","first-page":"257058","article-title":"Targeting insulin and insulin-like growth factor pathways in epithelial ovarian cancer","volume":"2010","author":"Gotlieb","year":"2010","journal-title":"J Oncol"},{"key":"53","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/MCO.0b013e328362d10b","article-title":"Linking obesity to colorectal cancer: recent insights into plausible biological mechanisms","volume":"16","author":"Murphy","year":"2013","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"54","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1158\/1535-7163.MCT-11-0545","article-title":"Direct role of adiponectin and adiponectin receptors in endometrial cancer:andstudies in humans","volume":"10","author":"Mantzoros","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"55","doi-asserted-by":"crossref","first-page":"e73183","DOI":"10.1371\/journal.pone.0073183","article-title":"The role of adiponectin in breast cancer: a meta-analysis","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"56","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/bjc.1995.71","article-title":"Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer","volume":"71","author":"Mancuso","year":"1995","journal-title":"Br J Cancer"},{"key":"57","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ijc.2910570305","article-title":"Interleukin-6 serum levels in patients with gynecological tumors","volume":"57","author":"Mancuso","year":"1994","journal-title":"Int J Cancer"},{"key":"58","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00109-013-1080-7","article-title":"The role of interleukin-6 in the evolution of ovarian cancer: clinical and prognostic implications\u2014a review","volume":"91","author":"Madeddu","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"59","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cyto.2012.04.020","article-title":"Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells","volume":"59","author":"Xu","year":"2012","journal-title":"Cytokine"},{"key":"60","doi-asserted-by":"crossref","first-page":"10794","DOI":"10.1158\/0008-5472.CAN-05-0623","article-title":"Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine","volume":"65","author":"Fidler","year":"2005","journal-title":"Cancer Res"},{"key":"61","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.18632\/oncotarget.2012","article-title":"Metformin limits the adipocyte tumor-promoting effect on ovarian cancer","volume":"5","author":"Rattan","year":"2014","journal-title":"Oncotarget"},{"key":"62","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"63","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/onc.2008.313","article-title":"PI3K\/Akt: getting it right matters","volume":"27","author":"Franke","year":"2008","journal-title":"Oncogene"},{"key":"64","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.3390\/ijms14048213","article-title":"The Importance of the PI3K\/AKT\/MTOR Pathway in the Progression of Ovarian Cancer","volume":"14","author":"Landen","year":"2013","journal-title":"Int J Mol Sci"},{"key":"65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tibs.2004.03.006","article-title":"Advances in protein kinase B signalling: AKTion on multiple fronts","volume":"29","author":"Hemmings","year":"2004","journal-title":"Trends Biochem Sci"},{"key":"66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2005.06.007","article-title":"An expanding role for mTOR in cancer","volume":"11","author":"Sabatini","year":"2005","journal-title":"Trends Mol Med"},{"key":"67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signaling","volume":"6","author":"Cantley","year":"2004","journal-title":"Cancer Cell"},{"key":"68","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.0308061100","article-title":"The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress","volume":"101","author":"Cantley","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"69","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ardp.201300402","article-title":"Role of AMP-activated protein kinase in cancer therapy","volume":"347","author":"Hamayun","year":"2014","journal-title":"Arch Pharm (Weinheim)"},{"key":"70","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4161\/auto.4240","article-title":"AMP-activated protein kinase: a universal regulator of autophagy?","volume":"3","author":"Jaattela","year":"2007","journal-title":"Autophagy"},{"key":"71","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10059-013-0138-2","article-title":"Nutrient regulation of the mTOR complex 1 signaling pathway","volume":"35","author":"Blenis","year":"2013","journal-title":"Mol Cells"},{"key":"72","doi-asserted-by":"crossref","first-page":"525","DOI":"10.18632\/aging.100481","article-title":"Caloric restriction: is mammalian life extension linked to p53?","volume":"4","author":"Tucci","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"73","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tem.2006.04.002","article-title":"SIRT1 and endocrine signaling","volume":"17","author":"Sauve","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"74","doi-asserted-by":"crossref","first-page":"25992","DOI":"10.1074\/jbc.M111.229401","article-title":"miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells","volume":"286","author":"Zhou","year":"2011","journal-title":"J Biol Chem"},{"key":"75","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1158\/1078-0432.CCR-08-3329","article-title":"Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma","volume":"15","author":"Jang","year":"2009","journal-title":"Clin Cancer Res"},{"key":"76","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1158\/0008-5472.CAN-07-0085","article-title":"SIRT1 is significantly elevated in mouse and human prostate cancer","volume":"67","author":"Nagy","year":"2007","journal-title":"Cancer Res"},{"key":"77","doi-asserted-by":"crossref","first-page":"42419","DOI":"10.1074\/jbc.R112.378877","article-title":"Sirtuin catalysis and regulation","volume":"287","author":"Denu","year":"2012","journal-title":"J Biol Chem"},{"key":"78","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/JOE-09-0345","article-title":"Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5","volume":"205","author":"Corder","year":"2010","journal-title":"J Endocrinol"},{"key":"79","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCRESAHA.109.215483","article-title":"SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells","volume":"106","author":"Wang","year":"2010","journal-title":"Circ Res"},{"key":"80","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Larter","year":"2006","journal-title":"Hepatology"},{"key":"81","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Horton","year":"2004","journal-title":"J Clin Invest"},{"key":"82","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Zang","year":"2011","journal-title":"Cell Metab"},{"key":"83","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.18632\/oncotarget.432","article-title":"NCI's provocative questions on cancer: some answers to ignite discussion","volume":"2","author":"Blagosklonny","year":"2011","journal-title":"Oncotarget"},{"key":"84","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1158\/0008-5472.CAN-07-2310","article-title":"Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells","volume":"67","author":"Sonenberg","year":"2007","journal-title":"Cancer Res"},{"key":"85","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.4161\/15384101.2014.985507","article-title":"Geroconversion: irreversible step to cellular senescence","volume":"13","author":"Blagosklonny","year":"2014","journal-title":"Cell cycle"},{"key":"86","first-page":"67","article-title":"[Effect of paternal drunkenness and smoking on child development]","author":"Selizar","year":"1988","journal-title":"Pediatriia"},{"key":"87","first-page":"715","article-title":"New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53\u2212\/\u2212 mice by delaying carcinogenesis","volume":"4","author":"Antoch","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"88","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/138161210789941874","article-title":"Cellular senescence in the development and treatment of cancer","volume":"16","author":"Saretzki","year":"2010","journal-title":"Curr Pharm Des"},{"key":"89","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2772","article-title":"Senescence in tumours: evidence from mice and humans","volume":"10","author":"Serrano","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"90","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nature05985","article-title":"The common biology of cancer and ageing","volume":"448","author":"Blasco","year":"2007","journal-title":"Nature"},{"key":"91","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/1940-6207.CAPR-12-0234","article-title":"Energy balance modulates mouse skin tumor promotion through altered IGF-1R and EGFR crosstalk","volume":"5","author":"DiGiovanni","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"92","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/1535370213493727","article-title":"Calorie restriction delays the progression of lesions to pancreatic cancer in the LSL-KrasG12D; Pdx-1\/Cre mouse model of pancreatic cancer","volume":"238","author":"Hess","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"key":"93","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1593\/neo.11148","article-title":"Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity","volume":"13","author":"Shridhar","year":"2011","journal-title":"Neoplasia"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T09:31:03Z","timestamp":1599557463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,26]]},"references-count":93,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,5,10]]}},"alternative-id":["3434","25895126"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.3434","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,26]]}}}